InvestorsHub Logo

TWilson07

02/24/20 8:33 AM

#238141 RE: TomP1 #238135

For every one reason they wouldn’t be, I can list five reasons why they still would be. Please provide the link saying that they terminated the agreement due to their research of the drug being an insufficient therapy. Wayne State and Biogen have been closely connected in the past, so you expect me to believe Wayne State puts out ANOTHER PIECE OF RESEARCH supporting our MOA yet Biogen disagrees or scoffs and completely dismisses it? I guess Biogen only picks and chooses which set of information they believe or support out of Wayne State based on the narrative being discussed huh? For a drug that has “no promise” to the Biochecking club, Anavex sure has been able to convince ALOT of people in the medical field otherwise.

anders2211

02/24/20 9:43 AM

#238155 RE: TomP1 #238135

It must not have impressed BIIB too much since they had the drug for testing.




Huh? Why do you assume that now that the paper is published it will not entice Biogen to take action? I mean the end conclusion is in for 1 day and already complaining Biogen is not investing in Anavex? Second most big pharma's have a wait and see until there is undeniable evidence attitude. They rather pay 8 billion too much after phase 3 then 200 million after paper evidence.